Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Prestige Consumer Healthcare Inc. or Perrigo Company plc because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Prestige Consumer Healthcare Inc. and Perrigo Company plc compare based on key financial metrics to determine which better meets your investment needs.

About Prestige Consumer Healthcare Inc. and Perrigo Company plc

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Latest Pharmaceuticals and Prestige Consumer Healthcare Inc., Perrigo Company plc Stock News

As of September 4, 2026, Prestige Consumer Healthcare Inc. had a $2.5 billion market capitalization, compared to the Pharmaceuticals median of $674.5 million. Prestige Consumer Healthcare Inc.’s stock is down 15.3% in 2026, down 0.4% in the previous five trading days and down 21.71% in the past year.

Currently, Prestige Consumer Healthcare Inc.’s price-earnings ratio is 14.6. Prestige Consumer Healthcare Inc.’s trailing 12-month revenue is $1.1 billion with a 15.6% net profit margin. Year-over-year quarterly sales growth most recently was 6.5%. Analysts expect adjusted earnings to reach $4.568 per share for the current fiscal year. Prestige Consumer Healthcare Inc. does not currently pay a dividend.

As of September 4, 2026, Perrigo Company plc had a $2.1 billion market cap, putting it in the 54th percentile of all stocks. Perrigo Company plc’s stock is up 7.2% in 2026, up 3% in the previous five trading days and down 35.94% in the past year.

Currently, Perrigo Company plc does not have a price-earnings ratio. Perrigo Company plc’s trailing 12-month revenue is $4.1 billion with a -41.9% net profit margin. Year-over-year quarterly sales growth most recently was -3.2%. Analysts expect adjusted earnings to reach $2.188 per share for the current fiscal year. Perrigo Company plc currently has a 7.8% dividend yield.

How We Compare Prestige Consumer Healthcare Inc. and Perrigo Company plc Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Prestige Consumer Healthcare Inc. and Perrigo Company plc’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Prestige Consumer Healthcare Inc. and Perrigo Company plc Stock Value Grades

Company	Ticker	Value
Prestige Consumer Healthcare Inc.	PBH	B
Perrigo Company plc	PRGO	A

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Prestige Consumer Healthcare Inc. has a Value Score of 71, which is Value. Perrigo Company plc has a Value Score of 96, which is Deep Value.

The Value Stock Winner: Perrigo Company plc

As you can clearly see from the Value Grade breakdown above, Perrigo Company plc is considered to have better value than Prestige Consumer Healthcare Inc.. For investors who focus solely on a company’s valuation, Perrigo Company plc could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Prestige Consumer Healthcare Inc. and Perrigo Company plc’s Momentum Grades

Company	Ticker	Momentum
Prestige Consumer Healthcare Inc.	PBH	D
Perrigo Company plc	PRGO	C

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Prestige Consumer Healthcare Inc. has a Momentum Score of 34, which is Weak. Perrigo Company plc has a Momentum Score of 41, which is Average.

The Momentum Stock Winner: No Clear Winner

Neither Prestige Consumer Healthcare Inc. or Perrigo Company plc has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Prestige Consumer Healthcare Inc. or Perrigo Company plc is the better investment when it comes to momentum.

Prestige Consumer Healthcare Inc. and Perrigo Company plc’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Prestige Consumer Healthcare Inc.	PBH	C
Perrigo Company plc	PRGO	B

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Prestige Consumer Healthcare Inc. has a Earnings Estimate Score of 42, which is Neutral. Perrigo Company plc has a Earnings Estimate Score of 72, which is Positive.

The Earnings Estimate Revisions Grade Winner: Perrigo Company plc

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Perrigo Company plc has a better Earnings Estimate Revisions Grade than Prestige Consumer Healthcare Inc.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Perrigo Company plc could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Prestige Consumer Healthcare Inc. and Perrigo Company plc Grades

In addition to Value, Momentum and Estimate Revisions, A+ Investor also provides grades for Growth and Quality.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Prestige Consumer Healthcare Inc. and Perrigo Company plc pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Prestige Consumer Healthcare Inc. or Perrigo Company plc Stock?

Overall, Prestige Consumer Healthcare Inc. stock has a Value Score of 71, Momentum Score of 34 and Estimate Revisions Score of 42.

Perrigo Company plc stock has a Value Score of 96, Momentum Score of 41 and Estimate Revisions Score of 72.

Comparing Prestige Consumer Healthcare Inc. and Perrigo Company plc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.